[go: up one dir, main page]

IL178821A0 - Direct and indirect modulation of composition and structure of cell membrane by ??-glycolipids - Google Patents

Direct and indirect modulation of composition and structure of cell membrane by ??-glycolipids

Info

Publication number
IL178821A0
IL178821A0 IL178821A IL17882106A IL178821A0 IL 178821 A0 IL178821 A0 IL 178821A0 IL 178821 A IL178821 A IL 178821A IL 17882106 A IL17882106 A IL 17882106A IL 178821 A0 IL178821 A0 IL 178821A0
Authority
IL
Israel
Prior art keywords
glycolipids
direct
composition
cell membrane
indirect modulation
Prior art date
Application number
IL178821A
Original Assignee
Ilan Yaron
Hadasit Med Res Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL175945A external-priority patent/IL175945A0/en
Application filed by Ilan Yaron, Hadasit Med Res Service filed Critical Ilan Yaron
Priority to IL178821A priority Critical patent/IL178821A0/en
Priority to PCT/IL2007/000633 priority patent/WO2007138574A2/en
Publication of IL178821A0 publication Critical patent/IL178821A0/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL178821A 2006-05-25 2006-10-23 Direct and indirect modulation of composition and structure of cell membrane by ??-glycolipids IL178821A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL178821A IL178821A0 (en) 2006-05-25 2006-10-23 Direct and indirect modulation of composition and structure of cell membrane by ??-glycolipids
PCT/IL2007/000633 WO2007138574A2 (en) 2006-05-25 2007-05-24 Monitoring responsiveness to and screening for therapeutic compounds that modulat composition and structure of cell membranes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL175945A IL175945A0 (en) 2006-05-25 2006-05-25 Direct and indirect modulation of composition and structure of cell membrane by ??-glycolipids
IL178821A IL178821A0 (en) 2006-05-25 2006-10-23 Direct and indirect modulation of composition and structure of cell membrane by ??-glycolipids

Publications (1)

Publication Number Publication Date
IL178821A0 true IL178821A0 (en) 2007-07-04

Family

ID=38779081

Family Applications (1)

Application Number Title Priority Date Filing Date
IL178821A IL178821A0 (en) 2006-05-25 2006-10-23 Direct and indirect modulation of composition and structure of cell membrane by ??-glycolipids

Country Status (2)

Country Link
IL (1) IL178821A0 (en)
WO (1) WO2007138574A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL187959A0 (en) * 2007-12-06 2008-12-29 Haim Lotan Beta glycolipids for the treatment of calcification related degenerative disorders
JP5465834B2 (en) * 2008-01-15 2014-04-09 雪印メグミルク株式会社 Liver function protectant
WO2013049220A1 (en) * 2011-09-30 2013-04-04 University Of Southern California Novel vaccination strategies or therapeutic treatment for influenza virus
ITMI20130513A1 (en) * 2013-04-05 2014-10-06 Euroclone S P A DIAGNOSTIC METHOD FOR AUTOIMMUNE PATHOLOGIES OF THE LIVER
US20250281672A1 (en) * 2021-07-30 2025-09-11 William Marsh Rice University Identification of pro- and anti-inflammatory lipids relating to immune response to medical implants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556763A (en) * 1992-04-06 1996-09-17 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Evaluation and treatment of patients with progressive immunosuppression
ID23495A (en) * 1997-04-10 2000-04-27 Kirin Brewery HCV CELL ACTIVE SUBSTANCES THAT CONTAIN ALPHA-GLYCOSYLSERAMIDE
IL172175A0 (en) * 2005-11-24 2011-08-01 Hadasit Med Res Service Beta glycolipids as immuno-modulators
CA2655947C (en) * 2006-06-30 2016-08-02 The Scripps Research Institute Compositions comprising nkt cell agonist compounds and methods of use

Also Published As

Publication number Publication date
WO2007138574A3 (en) 2009-04-23
WO2007138574A2 (en) 2007-12-06

Similar Documents

Publication Publication Date Title
IL267138A (en) Improved cell composition and methods of making the same
PL2356914T3 (en) Composition for improving membrane composition and functioning of cells
EP2208144A4 (en) Intelligent augmentation of media content
GB2469987B (en) Electrolyte composition
EP2260528A4 (en) Electrochemical cell and membranes related thereto
SI2132562T1 (en) Methods of evaluating cells and cell cultures
EP2069477A4 (en) Chemorepulsion of cells
GB0600972D0 (en) Enrichment of cells
EP2227540A4 (en) De-differentiation of human cells
EP2109172A4 (en) Electrolyte membrane
IL199639A0 (en) Improvement of cell growth
WO2011031875A9 (en) Cell-based compositions and uses thereof
IL178821A0 (en) Direct and indirect modulation of composition and structure of cell membrane by ??-glycolipids
EP1965455A4 (en) Sealing structure of fuel cell
EP1889061A4 (en) Modulation of t cell recruitment
IL175945A0 (en) Direct and indirect modulation of composition and structure of cell membrane by ??-glycolipids
EP2130915A4 (en) Cell capable of expressing lacritin at high level
GB0509318D0 (en) TCR-independent activation of T cells
HK1109928A (en) Modulation of t cell recruitment
GB0820492D0 (en) Cell compositions and uses thereof
AU2007907100A0 (en) Methods of modulating cellular activity and compositions therefor
GB0819611D0 (en) Electrochemical cells and components thereof
AU2007905307A0 (en) Modulation of B-tubulin expression in tumour cells
AU2007906770A0 (en) Nutraceutical composition and methods of use
AU2007906771A0 (en) Nutraceutical composition and methods of use